A Study to Evaluate the Effects of Esketamine on Cardiac Repolarization in Healthy Participants
Clinical trial NCT02737605 · COMPLETED
Trial details
- NCT number
- NCT02737605
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2017-02-23
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.